Who Owns Prelude Therapeutics Stock?
NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 76.42%
- Held by insiders
- 13.76%
- Institutional holders
- 107
- Institutions 76.4%
- Insiders 13.8%
- Public and other 9.8%
Who owns Prelude Therapeutics stock?
Institutional investors own about 76.4% of Prelude Therapeutics's shares, spread across 107 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 13.76% of PRLD.
The largest institutional holders are Orbimed Advisors LLC. (24.32%), Baker Bros. Advisors, LP (12.69%) and RA Capital Management, L.P. (8.11%). Together, the top 10 institutions control 60.8% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their PRLD positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PRLD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 19.40M | 24.32% | +17.0% |
| Baker Bros. Advisors, LP | 10.12M | 12.69% | 0.0% |
| RA Capital Management, L.P. | 6.48M | 8.11% | +100.0% |
| Soleus Capital Management, L.P. | 3.38M | 4.23% | +100.0% |
| Kynam Capital Management, LP | 2.42M | 3.03% | +51.6% |
| Vanguard Capital Management LLC | 2.01M | 2.52% | +63.3% |
| Blackrock Inc. | 1.80M | 2.25% | +458.4% |
| Sphera Funds Management Ltd. | 1.02M | 1.28% | +82.7% |
| Two Sigma Investments, LP | 993.37K | 1.24% | +7.5% |
| Adar1 Capital Management, LLC | 900.90K | 1.13% | +489.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PRLD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.51M | 1.90% |
| iShares Trust-iShares Russell 2000 ETF | 648.11K | 0.81% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 458.36K | 0.57% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 303.52K | 0.38% |
| iShares Trust-iShares Russell 2000 Growth ETF | 262.73K | 0.33% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 193.84K | 0.24% |
| SEI INSTITUTIONAL MANAGED TRUST-SIMT TAX-MANAGED SMALL/MID CAP FUND | 182.12K | 0.23% |
| iShares Trust-iShares Micro-Cap ETF | 92.47K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 69.21K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 68.42K | 0.09% |
Frequently asked questions
Who is the largest shareholder of Prelude Therapeutics?
Orbimed Advisors LLC. is the largest institutional shareholder of PRLD, owning 24.32% of shares outstanding (19.40M shares) as of its latest 13F filing.
What percentage of Prelude Therapeutics is owned by institutions?
Institutions own about 76.4% of PRLD shares and 88.6% of the public float.
How much of Prelude Therapeutics do insiders own?
Insiders, such as officers and directors, own about 13.76% of PRLD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.